HomeCompareVEMLY vs MRK

VEMLY vs MRK: Dividend Comparison 2026

VEMLY yields 3.16% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VEMLY wins by $532.58M in total portfolio value
10 years
VEMLY
VEMLY
● Live price
3.16%
Share price
$61.10
Annual div
$1.93
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$532.64M
Annual income
$502,067,393.30
Full VEMLY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — VEMLY vs MRK

📍 VEMLY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVEMLYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VEMLY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VEMLY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VEMLY
Annual income on $10K today (after 15% tax)
$268.19/yr
After 10yr DRIP, annual income (after tax)
$426,757,284.31/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, VEMLY beats the other by $426,748,955.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VEMLY + MRK for your $10,000?

VEMLY: 50%MRK: 50%
100% MRK50/50100% VEMLY
Portfolio after 10yr
$266.35M
Annual income
$251,038,595.72/yr
Blended yield
94.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VEMLY
No analyst data
Altman Z
92.7
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VEMLY buys
0
MRK buys
0
No recent congressional trades found for VEMLY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVEMLYMRK
Forward yield3.16%2.76%
Annual dividend / share$1.93$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$532.64M$56.8K
Annual income after 10y$502,067,393.30$9,798.13
Total dividends collected$530.39M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VEMLY vs MRK ($10,000, DRIP)

YearVEMLY PortfolioVEMLY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,331$631.04$11,206$366.19+$125.00VEMLY
2$13,461$1,336.51$12,650$502.35+$811.00VEMLY
3$17,371$2,967.67$14,407$694.19+$3.0KVEMLY
4$25,745$7,158.30$16,585$967.82+$9.2KVEMLY
5$47,377$19,830.38$19,342$1,363.89+$28.0KVEMLY
6$118,905$68,211.50$22,913$1,947.19+$96.0KVEMLY
7$447,217$319,988.13$27,662$2,823.89+$419.6KVEMLY
8$2,728,079$2,249,556.59$34,159$4,173.35+$2.69MVEMLY
9$28,568,720$25,649,676.29$43,337$6,308.80+$28.53MVEMLY
10$532,635,924$502,067,393.30$56,776$9,798.13+$532.58MVEMLY

VEMLY vs MRK: Complete Analysis 2026

VEMLYStock

Venture Corporation Limited provides technology solutions, products, and services in Singapore, the Asia Pacific, and internationally. The company operates through Advanced Manufacturing & Design Solutions, and Technology Products & Design Solutions segments. It engages in the design, manufacture, assemble, installation, and distribution of electronic, and other computer products and peripherals; manufacture and sale of terminal units; development and marketing of color imaging products for label printing; and research and development of biotechnology, life, and medical science products, as well as engages in repair of engineering and scientific instruments. The company is also involved in the provision of engineering, customization, logistics, and repair services; information system development and support services; design solutions and services; administrative and technical, and management services; and manufacturing, product design and development, engineering, and supply-chain management services. In addition, it engages in the manufacturing, fabricating, and dealing of precision plastic tools, components and sub-assemblies; design, customization, and marketing of tool-making and precision engineering solutions; manufacture of plastic injection molds and moldings with secondary processes and subassembly; manufacture of high technology products; and import and export of electronic parts, components, equipment, devices, and instruments. Further, the company wholesales computer hardware and peripheral equipment; manufactures and repairs engineering and scientific instruments; and manufactures and sells data and telecommunications products in industrial electronics industries. Additionally, the company manages portfolio of approximately 5,000 products and solutions. Venture Corporation Limited was incorporated in 1984 and is headquartered in Singapore.

Full VEMLY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VEMLY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VEMLY vs SCHDVEMLY vs JEPIVEMLY vs OVEMLY vs KOVEMLY vs MAINVEMLY vs JNJVEMLY vs ABBVVEMLY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.